The Top 50 Generic Drug Producers Had Combined Revenues Of $92bn In 2016

Friday 1 September 2017, Amsterdam

Market Research Report Press Release This report, now available on ASDReports, has launched a new pharma report Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027: North America, Europe, India, Japan, South Africa, MENA.

With patent expiries of blockbuster drugs, the generic drugs industry grows more important to the overall pharmaceutical market. Big Pharma are now realising the potential of generics to become a leading source of revenue over the next 10 years. The increasing penetration of generics in both developed and emerging markets has lead industry giants such as Novartis, Sanofi, Abbott and Pfizer to capitalise on this market. This study provides an assessment of the leading generic drug developers, producers and sellers, assessing their strategies and prospects from 2017.

The key player report analyst commented “The key player believes the forecast period will see more traditional pharma companies embrace generic business units in order to take advantage of higher growth rates in generics. At the same time, successful generic companies will try to innovate, pursuing more research-based pipeline candidates as well as high-value generics and biosimilars. However, generic drug manufacturers must continuously revise their business models in an attempt to outsmart market challenges. New strategic decisions will have to be made to define their future path. This may include steps such as merging for scale, complementing the generic portfolio with a branded portfolio, or adding new offerings and services in order to provide new revenue streams.

Taking advantage of the opportunities in this fast-growing, extremely competitive market will require generics manufacturers to sustain highly efficient production and distribution capacity and to expand their global presence through targeted acquisitions. Companies will need to be vigilant in taking advantage of growth sectors within the market, and aggressive in their pursuit of first-to-file applications”


Leading companies featured in the report who manufacture generic drugs include Teva, Mylan, Pfizer, Abbott, Novartis, Sanofi, Fresenius Kabi, Sun Pharmaceutical Industries, Dr. Reddy’s, Lupin, EMS, Cipla, Perrigo, Abdi Ibrahim and other leading companies.
Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027

Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027

Publish date : July 2017
Report code : ASDR-410186
Pages : 214

ASDReports.com Media contact: S. Koopman - Marketing and Communications

ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E : stefan.koopman@asdreports.com

 back to News